Bipolar Study in Adults at Least 18 Years of Age

Completed · Phase 4

Conditions studied: Bipolar Disorder

In brief

Bipolar study of tolerability, clinical response and patient satisfaction

Key facts

Study ID

NCT00067938

Run by

GlaxoSmithKline

People needed

1200

Starts

2003-08-01

Expected to finish

2004-08-01

Last updated by the study team

2016-09-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of bipolar I disorder.
• Must be on a stable regimen of psychiatric medication for at least 2 months prior to study.
• If female, must not be pregnant, or must be incapable of conceiving or be taking steps to prevent conception.

You may not qualify if…

• Patients with a clinically significant psychiatric or physiologic comorbidity including significant substance abuse, depression or mania which is of an unstable of progressive nature that could interfere in participation of this study.
• Presence of untreated thyroid disease.
• Patient is actively suicidal or homicidal.
• Patient has history of severe hepatic or renal insufficiency.
• Patient is currently participating in another clinical trial.

Where it is running

• GSK Investigational Site — Anniston, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Fairhope, Alabama, United States
• GSK Investigational Site — Huntsville, Alabama, United States
• GSK Investigational Site — Tuscaloosa, Alabama, United States
• GSK Investigational Site — Chandler, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Rogers, Arizona, United States
• GSK Investigational Site — Tucson, Arizona, United States
• GSK Investigational Site — Fort Smith, Arkansas, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — North Little Rock, Arkansas, United States
• GSK Investigational Site — Bakersfield, California, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Burbank, California, United States
• GSK Investigational Site — Campbell, California, United States
• GSK Investigational Site — Cerritos, California, United States
• GSK Investigational Site — El Centro, California, United States
• GSK Investigational Site — Fairfield, California, United States
• GSK Investigational Site — Albertville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.